Fidelity Advisor Biotechnology Fund ABBV Holdings History
Fidelity Advisor Biotechnology Fund's AbbVie Inc Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 1.92 Mil shares of AbbVie Inc(ABBV), totaling $20.00. This investment constitutes 0% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.11% of the outstanding AbbVie Inc(ABBV) stock.
The initial trade took place in 2019Q4. And since then Fidelity Advisor Biotechnology Fund has made 8 purchases of ABBV, at an average price of $118.19, for a total of 13.87 Mil shares. In addition, there have been 13 sales at an average price of $137.28 for 11.95 Mil shares. Based on historical transaction data and ABBV's current price of $187.66, Fidelity Advisor Biotechnology Fund's estimated gain on his ABBV holdings is $361.22 Mil, reflecting a 22.04% gain to date.
Fidelity Advisor Biotechnology Fund ABBV ($187.66) Holding Chart
Fidelity Advisor Biotechnology Fund ABBV ($187.66) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
